Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndrome.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| KCT-0809 ophthalmic solution, low dose | Experimental |
| |
| KCT-0809 ophthalmic solution, high dose | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| KCT-0809 | Drug |
| ||
| KCT-0809 |
| Measure | Description | Time Frame |
|---|---|---|
| Corneal staining score | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Conjunctival staining score | 6 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Katsumi Hontani | Clinical Development Department, Kissei pharmaceutical Co., Ltd. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Japan | Tokyo and Other Japanese City | Japan |
Not provided
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| D003316 | Corneal Diseases |
| D003229 | Conjunctival Diseases |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Placebo | Drug |
|